Invest in PlantForm
PlantForm is a private Canadian biotech company established in 2008. Investment opportunities are available as PlantForm commercializes its proprietary vivoXPRESS® technology platform for plant-made pharmaceuticals.
The company has secured financing of $5.5 million to date from founders, management, angel investors, and U.K.-based Atlantic Assets Trust. PlantForm is currently seeking a Series A round of financing of up to $20 million.
For more information, please contact:
President and CEO
"PlantForm is ideally positioned to meet the fast-growing demand for affordable antibody medicines: it has a novel, versatile and scalable manufacturing platform with an excellent management team that can execute on a well thought-out plan."
President & CEO, Dalton Chemical Laboratories Inc.